Update cookies preferences

Free Download

Efficacy and side effects of antibiotics in the treatment of acute rhinosinusitis: a systematic review

Volume: 53 - Issue: 1

First page: 3 - Last page: 9

WJ Sng - DY Wang

BACKGROUND: Acute rhinosinusitis (ARS) is one of the most common diagnoses for which an antibiotic is prescribed. Although the usage of antibiotics in the treatment of mild, moderate or uncomplicated ARS is not recommended by most international guideli- nes, overuse of antibiotics is still an alarming problem among patients and healthcare practitioners. We thus sought to review the evidence available through a systematic review of the existing literature on antibiotic usage in ARS.
METHODOLOGY: A search of the PubMed database was conducted for studies on antibiotic and placebo usage in the treatment of ARS.
RESULTS: A total of 31 random control trials (RCT) reporting the clinical efficacy of treating ARS and side effects of using cefuroxime axetil, telithromycin, amoxicillin/potassium clavulanate, levofloxacin, moxifloxacin and clarithromycin were included in the review. Among them, 9 studies were performed double-blinded with placebo controls. The results showed that while antibiotics are more efficacious than placebos in the treatment of ARS, the risks of potential side effects need to be weighed against the potential be- nefit that antibiotics give to the patient. This is especially pertinent as usage of the placebo has shown to be almost as efficacious as using the antibiotic therapy, and also much safer.
CONCLUSION: The usage of antibiotics in ARS is widespread and there seems to be only slight added benefit in the usage of antibi- otics over placebo in the treatment of ARS. Hence, larger scale studies should be done in the future to confirm the results of these studies.

Rhinology 53-1: 3-9, 2015

To see the issue content and the abstract you do not have to login

Please login to download the full articles

If you do not have a subscription to Rhinology please consider taking one.

Click here to become a member of the European Rhinologic Society and a subscriber to the journal `RHINOLOGY`, from 2024. Subscription including membership fee: Euro 135.-